These results indicate that while DLGAP2 overexpression does not directly modify synaptic throughput, there may be a synergistic effect of DLGAP2 expression with AD pathology that minimizes age‐related changes on the strength of synaptic signaling. This evidence concerns the gene DLGAP2 and Alzheimer disease.